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Dengue is the most rapidly advancing vector-borne disease,
with an estimated 50 million infections occurring annually.1 The
occurrence of dengue in pregnancy has been described in the
literature since 1948,2 mostly in the form of case reports, with the
two largest series reported from French Guiana, involving 38
cases3 and 53 cases.4 In the last two decades, the ﬁrst reports of
vertical transmission and maternal deaths related to infection with
the dengue virus (DENV) have been conﬁrmed.5–7
The aim of this study was to investigate the pathological
changes found in the placentas of women infected with DENV.
Twenty-eight placentas and seven ovular remnants were analyzed
by macroscopic examination after ﬁxation in 10% formalin.
Cleavage was performed, and seven samples were retrieved from
the placenta and annexes. Samples were subsequently stained
using hematoxylin–eosin (HE). The ovular membranes, umbilical
cord, and placental tissue were observed by histological study.
The mean maternal age was 24  7 years, the mean gestational
age of the infants at birth was 38  2 weeks, and the mean birth
weight was 2953  531 g. Seventy-eight percent of events (birth,
stillbirth, and abortion) occurred in the period of maternal viremia.
The main pathological changes were deciduitis in 14 (40%),
coriodeciduitis in 12 (34%), intervillositis in 10 (28.5%), villositis in
10 (28.5%), and hypoxia in 26 (74%) (villous stromal edema, excessive
formation of syncytial knots, corioangiosis). Five showed erythrocyte
sickling in the placental intervillous space. None of these patients had
a history of sickle-cell disease. All showed warning signs, usually
predictors of severe illness and indicative of capillary leak syndrome,
and were classiﬁed as dengue hemorrhagic fever.8 One progressed to
dengue shock syndrome and died.
Using the Fisher’s exact test at the a = 0.05 signiﬁcance level,
the sample data provided valuable insights into a trend of
association between the presence of sickle erythrocytes and the
presence of warning signals in the mother (Fisher’s exact test,
bilateral p-value = 0.057, and unilateral p-value = 0.048).
Sickle cell anemia is associated with a fatal outcome in patients
infected with DENV,9 but there is no reference about the sickle-cell
trait, which in the presence of hypoxia may sickle the red blood
cells that are deposited in the intervillous space. It may be a
surrogate marker of severity in pregnant women with dengue,
especially in a population like that of Brazil, which has
approximately 2% HbS carriers, reaching 5% among negroids.10
Further studies should conﬁrm this association.1201-9712/$36.00 – see front matter  2011 Published by Elsevier Ltd on behalf of In
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